Launched in April 2015, Asia Pacific Medical Technology Association (APACMed) aims to “improve the standards of care for patients through innovative collaborations among stakeholders to jointly shape the future of healthcare in Asia Pacific.”
In December 2015, APACMed held a two-day conference- the Asia Pacific MedTech Forum 2015, the region’s leading event for medical technology professionals to address issues driving the industry and how innovation and collaboration are vital to help solve the unmet healthcare needs of people in Asia Pacific. During the event, McKinsey&Company presented the white paper report which examined and analyzed the opportunities and challenges facing the medical technology industry in the region and recommended areas where the industry can collaborate to drive change.
In a two-part series, biotechin.asia is featuring key members of the APACMed committee and bringing forth the highlights of the recently concluded APACMedTech forum. In the first part of this series, we spoke to the CEO of APACMed, Fredrik Nyberg. In today’s series, we will be talking to Anna Maria Braun and Vladimir Makatsaria who are part of APACMed.
Anna Maria Braun
President, Asia Pacific & Member of the Management Board B. Braun Medical Industries
Anna Maria Braun is President, Asia Pacific of B.Braun Medical Industries. In this role, she is responsible for the Group’s pharmaceutical and medical technology business in the Asia Pacific region. Based in the Regional Headquarters in Penang, Malaysia, Ms. Braun also oversees one of the Group’s largest production sites. Ms. Braun is a qualified Attorney-at Law with a degree in Law from the University of Freiburg, Germany and a Masters in Law from Georgetown University in Washington, DC. She has been admitted to the Bar in Germany and in New York State, USA.
How has the conference been till now? What were the key outcomes of the conference?
I am very happy that the inaugural conference organised by the APACMed association received such a good response and strong support from the industry and other stakeholders. We had great discussions and inspiring talks especially the personal account by Trish Hepburn, the brave cancer survivor, who set the stage and reminded us that we all need to work on common goals to improve access and the standards of care through innovative collaborations, to jointly shape the future of healthcare in Asia Pacific.
What are some of the roadblocks ahead, which the MedTech forum needs to address?
The McKinsey white paper outlines a few key challenges very well: education, capacity building and the need for innovative solutions to cater to the broader market segments. APACMed has already started the momentum by forming Committees such as Government Affairs, Legal & Ethics, Regulatory Affairs, Communications, Medical & Clinical Affairs to address some of these challenges and provide a collaborative platform for industry players and other stakeholders.
It is amazing and inspiring to know that you have a Law degree and are heading a huge MedTech company now. How has the journey been? Can you tell us a bit about the transition/your story?
I always wanted to be a lawyer and still enjoy law very much. After a few years of working in a law firm, however, I decided that I wanted to be actively involved in the management of a business, and not merely consulted when it came to legal issues. Having a legal background is, in my opinion, a good foundation for positions in Management or Business, as it trains one in the structuring of thoughts.
Vladimir Makatsaria, Chairman of APACMed
Company Group Chairman Johnson & Johnson
Vladimir Makatsaria is Company Group Chairman at Johnson & Johnson, with leadership responsibility for the Global Surgery Group in Asia Pacific. Vladimir began his career with Johnson & Johnson as a cardiovascular sales representative in Russia in 1996. He went on to hold several general management positions of increasing responsibility, including Managing Director in Russia, Area Director in Eastern Europe, Vice President of Strategic Affairs for Europe, Middle East and Africa, President of Ethicon in Europe, Middle East and Africa. Vladimir is a member of the Advisory Board of the Singapore Management University, Lee Kong Chian School of Business.
Heading an MNC, what are your expectations from this conference?
Healthcare is at an inflection point in Asia Pacific. Two-thirds of the world’s populations live in Asia, and the healthcare needs of the majority of patients remain unmet today. The Asia Pacific MedTech Forum is an excellent platform to discuss important issues that accelerate standards of care in Asia Pacific and most of all serve our patients in this region. As the themes of the conference focused on Access, Innovation and Collaboration, it is our expectation that members will work together with important stakeholders to advance this agenda in the region.
How has the MedTech Forum experience been?
The MedTech Forum has definitely been an enriching experience and I’m proud to have been a part of this momentous day in the history of medical devices. The Forum attracted nearly 500 delegates. It has been an incredible journey for the industry to reach this point. Coming away from this Forum, I believe everyone feels equally committed to work together to meet the growing needs of the region.
How do you think your company can evolve to better serve your customers in APAC?
If we truly want to escalate access for patients in Asia Pacific, we have to think beyond what individual companies can do and consider the role an organization like APACMed plays in the region. APACMed is uniquely positioned to bring together the various companies in the medical technology industry and harmonize the region with one united stance.